{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:13:47Z","timestamp":1788236027391,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010148","name":"Asociaci\u00f3n Espa\u00f1ola de Urolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010148","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.acuroe.2026.501994","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T06:04:47Z","timestamp":1779689087000},"page":"501994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Improving long-term monitoring in NMIBC: Digital Uromonitor\u00ae (dUM) as a complementary tool to cystoscopy for two-year recurrence risk stratification"],"prefix":"10.1016","volume":"50","author":[{"given":"J.","family":"Rubio-Briones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Guerrero Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mercad\u00e9 S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Bezana Abad\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mart\u00edn Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Alcaraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Miqueleiz Legaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Arrabal Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Cardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Gonzalo Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ca\u00f1o Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Serrano Liesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ferreiro Pareja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Esp\u00edlez Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Gonz\u00e1lez-Valc\u00e1rcel de Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"S\u00e1nchez Zalabardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Guijarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mengual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Borque-Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mariano Esteban Esca\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Palou Redorta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Witjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mart\u00ednez Pi\u00f1eiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuroe.2026.501994_bib0005","article-title":"Recurrence, progression, and follow-up in non-muscle-invasive bladder cancer","volume":"8","author":"Heijden","year":"2009","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.acuroe.2026.501994_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41585-022-00578-1","article-title":"Recurrence mechanisms of non-muscle-invasive bladder cancer \u2014 a clinical perspective","volume":"19","author":"Teoh","year":"2022","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.acuroe.2026.501994_bib0015","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.urolonc.2021.05.015","article-title":"Non-muscle-invasive bladder cancer: an overview of potential new treatment options","volume":"39","author":"Shore","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.acuroe.2026.501994_bib0020","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3390\/cancers17101714","article-title":"Active surveillance in Non-muscle invasive bladder cancer: a systematic review","volume":"17","author":"Campistol","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.acuroe.2026.501994_bib0025","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2026.501994_bib0030","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/bjc.2013.372","article-title":"Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder","volume":"109","author":"Xylinas","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.acuroe.2026.501994_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14205019","article-title":"Predicting recurrence of non-muscle-invasive bladder cancer: current techniques and future trends","volume":"14","author":"Shalata","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.acuroe.2026.501994_bib0040","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3390\/diagnostics10100745","article-title":"Clinical validation of a urine test (Uromonitor-V2(\u00ae)) for the surveillance of non-muscle-invasive bladder cancer patients","volume":"10","author":"Sieverink","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.acuroe.2026.501994_bib0045","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3390\/cancers16040753","article-title":"Urine-based biomarker test Uromonitor(\u00ae) in the detection and disease monitoring of non-muscle-invasive bladder cancer-a systematic review and meta-analysis of diagnostic test performance","volume":"16","author":"Kravchuk","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.acuroe.2026.501994_bib0050","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/bju.16450","article-title":"Real-world performance of Uromonitor\u00ae in urothelial bladder cancer detection: a multicentric trial","volume":"134","author":"Wolff","year":"2024","journal-title":"BJU Int"},{"key":"10.1016\/j.acuroe.2026.501994_bib0055","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bju.70010","article-title":"External validation of the Uromonitor\u00ae-version 2 urine test as a biomarker for optimisation of non-muscle-invasive bladder cancer management","volume":"137","author":"Rubio-Briones","year":"2026","journal-title":"BJU Int"},{"key":"10.1016\/j.acuroe.2026.501994_bib0060","doi-asserted-by":"crossref","DOI":"10.3390\/s18041271","article-title":"dPCR: a technology review","volume":"18","author":"Quan","year":"2018","journal-title":"Sensors (Basel)"},{"key":"10.1016\/j.acuroe.2026.501994_bib0065","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","article-title":"European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panel","volume":"79","author":"Sylvester","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2026.501994_bib0070","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.euo.2021.11.006","article-title":"Updated European Association of Urology (EAU) prognostic factor risk groups overestimate the risk of progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Gu\u00e9rin","volume":"5","author":"Lobo","year":"2022","journal-title":"Eur Urol Oncol"},{"issue":"4","key":"10.1016\/j.acuroe.2026.501994_bib0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/PAP.0000000000000118","article-title":"The Paris system for reporting urinary cytology: the quest to develop a standardized terminology","volume":"23","author":"Barkan","year":"2016","journal-title":"Adv Anat Pathol."},{"key":"10.1016\/j.acuroe.2026.501994_bib0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3233\/BLC-230096","article-title":"Noninvasive tests for bladder cancer detection and surveillance: a systematic review of commercially available assays","volume":"10","author":"Heard","year":"2024","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.acuroe.2026.501994_bib0085","article-title":"Limited value of bladder wash cytology during follow-up of patients with non-muscle invasive bladder cancer","volume":"15","author":"Bieri","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.acuroe.2026.501994_bib0090","doi-asserted-by":"crossref","first-page":"27.e1","DOI":"10.1016\/j.urolonc.2012.09.011","article-title":"Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer","volume":"32","author":"Yafi","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.acuroe.2026.501994_bib0095","series-title":"The usage of the Paris classification system in urine cytology in the diagnosis of non-invasive bladder cancer: a retrospective single-center study","author":"Saarinen","year":"2024"},{"key":"10.1016\/j.acuroe.2026.501994_bib0100","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/MOU.0000000000000078","article-title":"The burden of bladder cancer care: direct and indirect costs. Current opinion in urology","volume":"24","author":"Mossanen","year":"2014","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.acuroe.2026.501994_bib0105","doi-asserted-by":"crossref","first-page":"449.e21","DOI":"10.1016\/j.urolonc.2024.07.009","article-title":"Clinical performance of Bladder EpiCheck\u2122 versus voided urine cytology for detecting recurrence of nonmuscle invasive Bladder cancer: systematic review and meta-analysis","volume":"42","author":"Chiang","year":"2024","journal-title":"Urol Oncol"},{"key":"10.1016\/j.acuroe.2026.501994_bib0110","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00345-022-04253-3","article-title":"Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review","volume":"41","author":"Soorojebally","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.acuroe.2026.501994_bib0115","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.juro.2016.12.010","article-title":"Performance characteristics of a multigene urine biomarker test for monitoring for recurrent urothelial carcinoma in a multicenter study","volume":"197","author":"Kavalieris","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2026.501994_bib0120","doi-asserted-by":"crossref","first-page":"531.e15","DOI":"10.1016\/j.urolonc.2017.03.008","article-title":"Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma","volume":"35","author":"Lotan","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.acuroe.2026.501994_bib0125","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1186\/s12885-016-2748-5","article-title":"Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive\/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer","volume":"16","author":"Roperch","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.acuroe.2026.501994_bib0130","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/bju.15194","article-title":"Comparison of the performances of the ADXBLADDER test and urinary cytology in the follow-up of non-muscle-invasive bladder cancer: a blinded prospective multicentric study","volume":"127","author":"Gontero","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.acuroe.2026.501994_bib0135","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.urology.2015.07.036","article-title":"The diagnostic and prognostic performance of urinary FGFR3 mutation analysis in bladder cancer surveillance: a prospective multicenter study","volume":"86","author":"Couffignal","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.acuroe.2026.501994_bib0140","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.euo.2025.04.020","article-title":"Results of the prospective randomized UroFollow trial comparing marker-guided versus cystoscopy-based surveillance in patients with low\/Intermediate-risk bladder cancer","volume":"8","author":"Schmitz-Dr\u00e4ger","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.acuroe.2026.501994_bib0145","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.eururo.2020.07.009","article-title":"The DaBlaCa-13 study: short-term, intensive chemoresection versus standard adjuvant intravesical instillations in Non-muscle-invasive bladder cancer-a randomised controlled trial","volume":"78","author":"Lindgren","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2026.501994_bib0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2026.501994_bib0155","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3892\/ijo.2025.5724","article-title":"Unleashing the power of urine\u2011based biomarkers in diagnosis, prognosis and monitoring of bladder cancer (Review)","volume":"66","author":"Wan","year":"2025","journal-title":"Int J Oncol"},{"key":"10.1016\/j.acuroe.2026.501994_bib0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/UA.UA_143_18","article-title":"Is cystoscopy follow-up protocol safe for low-risk bladder cancer without muscle invasion?","volume":"12","author":"Yucetas","year":"2020","journal-title":"Urol Ann"},{"key":"10.1016\/j.acuroe.2026.501994_bib0165","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/nsr\/nwaa007","article-title":"DNA storage: research landscape and future prospects","volume":"7","author":"Dong","year":"2020","journal-title":"Natl Sci Rev"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578626001058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578626001058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:17:36Z","timestamp":1788232656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578626001058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2173578626001058"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2026.501994","relation":{},"ISSN":["2173-5786"],"issn-type":[{"value":"2173-5786","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving long-term monitoring in NMIBC: Digital Uromonitor\u00ae (dUM) as a complementary tool to cystoscopy for two-year recurrence risk stratification","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2026.501994","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2026.501994","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501994"}}